Doctor profile · Federal record
Dr. Mark Schutta, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Philadelphia, PA
- NPI 1396775458
- Accepts Medicare
- MIPS 85.5 / 100 · 2023
- 33 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3400 Civic Center Boulevard, West Pavilion 4Th Floor
Philadelphia, PA 191045134
(215) 662-2300
fax (215) 614-0418
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- May 22, 2012
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Pennsylvania #MD059656L
- Medicaid
- PA #0017801200003
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1396775458. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
902
Distinct HCPCS
5
Medicare allowed
$74,142
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 574 | 292 | $101 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 277 | 143 | $36 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 19 | 16 | $99 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 18 | 18 | $135 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 14 | 14 | $130 |
In context: peer comparison
Among 28 peers in this city , average services per provider: 78. This provider delivers 12× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
2,741
Patients
880
Total drug cost
$2,165,861
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metformin Hcl Er (Metformin Hcl) | Brand | 348 | 115 | $9,418 |
| Januvia (Sitagliptin Phosphate) | Brand | 263 | 77 | $345,187 |
| Metformin Hcl | Generic | 249 | 71 | $4,077 |
| Novolog Flexpen (Insulin Aspart) | Brand | 221 | 85 | $320,433 |
| Ozempic (Semaglutide) | Brand | 214 | 45 | $349,142 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 213 | 80 | $137,916 |
| Glimepiride | Generic | 198 | 64 | $3,240 |
| Trulicity (Dulaglutide) | Brand | 196 | 54 | $412,675 |
| Jardiance (Empagliflozin) | Brand | 165 | 48 | $230,651 |
| Humalog Kwikpen U-100 (Insulin Lispro) | Brand | 163 | 54 | $180,095 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Schutta's medical specialty?
Dr. Mark Schutta practices Endocrinology, Diabetes & Metabolism Physician in Philadelphia, PA.
Where does Dr. Mark Schutta practice?
Dr. Mark Schutta practices at 3400 Civic Center Boulevard, Philadelphia, PA 191045134. Office phone: 2156622300.
What is Dr. Mark Schutta's NPI?
Dr. Mark Schutta's National Provider Identifier (NPI) is 1396775458, issued by NPPES.
Does Dr. Mark Schutta accept Medicare assignment?
Yes. Dr. Mark Schutta accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Schutta commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.